Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

772 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition.
Mishima S, Naito Y, Akagi K, Hayashi N, Hirasawa A, Hishiki T, Igarashi A, Ikeda M, Kadowaki S, Kajiyama H, Kato M, Kenmotsu H, Kodera Y, Komine K, Koyama T, Maeda O, Miyachi M, Nishihara H, Nishiyama H, Ohga S, Okamoto W, Oki E, Ono S, Sanada M, Sekine I, Takano T, Tao K, Terashima K, Tsuchihara K, Yatabe Y, Yoshino T, Baba E. Mishima S, et al. Among authors: yatabe y. Int J Clin Oncol. 2023 Oct;28(10):1237-1258. doi: 10.1007/s10147-023-02397-9. Epub 2023 Aug 20. Int J Clin Oncol. 2023. PMID: 37599324 Free PMC article.
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors.
Naito Y, Mishima S, Akagi K, Hayashi N, Hirasawa A, Hishiki T, Igarashi A, Ikeda M, Kadowaki S, Kajiyama H, Kato M, Kenmotsu H, Kodera Y, Komine K, Koyama T, Maeda O, Miyachi M, Nishihara H, Nishiyama H, Ohga S, Okamoto W, Oki E, Ono S, Sanada M, Sekine I, Takano T, Tao K, Terashima K, Tsuchihara K, Yatabe Y, Yoshino T, Baba E. Naito Y, et al. Among authors: yatabe y. Int J Clin Oncol. 2023 Jul;28(7):827-840. doi: 10.1007/s10147-023-02345-7. Epub 2023 May 22. Int J Clin Oncol. 2023. PMID: 37212982 Free PMC article.
The landscape of 142 Epstein-Barr viral whole genomes in gastric cancer.
Kojima Y, Hamada M, Naruse A, Goto K, Khine HT, Arai H, Akutsu Y, Satou A, Nakaguro M, Kato S, Kodera Y, Yatabe Y, Torii Y, Kawada JI, Murata T, Kimura H, Takiguchi S, Inagaki H, Kataoka H, Okuno Y. Kojima Y, et al. Among authors: yatabe y. J Gastroenterol. 2025 Jan;60(1):55-65. doi: 10.1007/s00535-024-02170-3. Epub 2024 Nov 21. J Gastroenterol. 2025. PMID: 39572460
The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer.
Edwards JG, Chansky K, Van Schil P, Nicholson AG, Boubia S, Brambilla E, Donington J, Galateau-Sallé F, Hoffmann H, Infante M, Marino M, Marom EM, Nakajima J, Ostrowski M, Travis WD, Tsao MS, Yatabe Y, Giroux DJ, Shemanski L, Crowley J, Krasnik M, Asamura H, Rami-Porta R; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members, and Participating Institutions. Edwards JG, et al. Among authors: yatabe y. J Thorac Oncol. 2020 Mar;15(3):344-359. doi: 10.1016/j.jtho.2019.10.019. Epub 2019 Nov 13. J Thorac Oncol. 2020. PMID: 31731014 Free article.
Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer.
Saw SPL, Zhong WZ, Fu R, Li MSC, Goto Y, Fox SB, Yatabe Y, Ong BH, Ng CSH, Lee DDW, Cam Phuong P, Park IK, Yang JCH, Tsuboi M, Tho LM, John T, Hsu HH, Tan DSW, Mok TSK, Reungwetwattana T, Singh N. Saw SPL, et al. Among authors: yatabe y. Lung Cancer. 2025 Jan 2;200:108076. doi: 10.1016/j.lungcan.2024.108076. Online ahead of print. Lung Cancer. 2025. PMID: 39799810 Free article. Review.
WEE1 confers resistance to KRASG12C inhibitors in non-small cell lung cancer.
Yamamoto G, Tanaka K, Kamata R, Saito H, Yamamori-Morita T, Nakao T, Liu J, Mori S, Yagishita S, Hamada A, Shinno Y, Yoshida T, Horinouchi H, Ohe Y, Watanabe SI, Yatabe Y, Kitai H, Konno S, Kobayashi SS, Ohashi A. Yamamoto G, et al. Among authors: yatabe y. Cancer Lett. 2024 Dec 24;611:217414. doi: 10.1016/j.canlet.2024.217414. Online ahead of print. Cancer Lett. 2024. PMID: 39725152 Free article.
NKX3.1 Helps Distinguish Hyalinizing Clear Cell Carcinoma From Other Clear Cell Salivary Gland Neoplasms.
Sakyo A, Ryo E, Nishino S, Kobayashi K, Yoshimoto S, Omura G, Fushimi C, Sakai T, Sakai A, Eguchi K, Takahashi H, Yokoyama K, Honma Y, Mori A, Kato H, Hatano T, Yoshida A, Matsumoto F, Yatabe Y, Mori T. Sakyo A, et al. Among authors: yatabe y. Lab Invest. 2024 Nov 29;105(3):102205. doi: 10.1016/j.labinv.2024.102205. Online ahead of print. Lab Invest. 2024. PMID: 39617100
772 results